The effects of "Hange-shashin-to (
TJ-14)" on gastric function were examined in comparison with "
Sho-saiko-to (TJ-9)". Oral treatment with
TJ-14 (125-500 mg/kg) caused dose-dependent suppression of
ethanol-induced gastric injury, while it did not suppress gastric lesions induced by water-immersion stress.
TJ-9 (125-500 mg/kg, p.o.) suppressed both water-immersion stress-induced gastric lesions and
ethanol-induced gastric injury in a dose-dependent manner. Intraduodenal administration of
TJ-14 even at 500 mg/kg did not affect gastric juice secretion, while
TJ-9 at 125 to 500 mg/kg dose-dependently suppressed gastric juice secretion.
TJ-14 (125-500 mg/kg, p.o.) accelerated gastric emptying in normal rats and improved the delayed gastric emptying induced by
BaCl2 in a dose-dependent manner, whereas such effect was not noted with
TJ-9. Oral treatment with
TJ-14 at 500 mg/kg significantly suppressed
apomorphine-induced
vomiting, but it did not affect
copper sulfate-induced
vomiting. These results suggest that
TJ-14 exhibits an anti-
ulcer action (probably based on its ability to protect the gastric mucosa), improvement of gastric emptying and an
anti-emetic action.
TJ-9 also showed anti-
ulcer effects, probably based on its ability to suppress gastric secretion and to protect the gastric mucosa. Thus, the present study demonstrated the effectiveness of
TJ-14 and
TJ-9 against
gastric disease, and provided basic data which explain the differences in clinical application between these two
kampo medicines.